share_log

Rockwell Medical Analyst Ratings

Benzinga ·  Oct 5, 2023 23:40
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/05/2023 144.5% Maxim Group → $5 Initiates Coverage On → Buy
10/04/2023 437.9% HC Wainwright & Co. → $11 Reiterates Buy → Buy
09/28/2023 437.9% HC Wainwright & Co. → $11 Reiterates Buy → Buy
08/15/2023 437.9% HC Wainwright & Co. → $11 Reiterates Buy → Buy
07/17/2023 437.9% HC Wainwright & Co. $9 → $11 Maintains Buy
05/30/2023 340.1% HC Wainwright & Co. $7 → $9 Maintains Buy
05/02/2023 242.3% HC Wainwright & Co. → $7 Reiterates → Buy
04/04/2023 242.3% HC Wainwright & Co. → $7 Reiterates → Buy
02/13/2023 242.3% HC Wainwright & Co. → $7 Reiterates → Buy
02/08/2023 242.3% HC Wainwright & Co. $8 → $7 Maintains Buy
08/30/2022 291.2% HC Wainwright & Co. $3 → $8 Maintains Buy
01/18/2022 46.7% HC Wainwright & Co. $5 → $3 Maintains Buy
09/07/2021 144.5% HC Wainwright & Co. $5.5 → $5 Maintains Buy
02/08/2021 168.95% HC Wainwright & Co. $9 → $5.5 Maintains Buy
04/07/2020 340.1% HC Wainwright & Co. $11 → $9 Maintains Buy
11/12/2019 193.4% Piper Sandler $10 → $6 Maintains Overweight
06/25/2019 437.9% Cantor Fitzgerald → $11 Initiates Coverage On → Overweight
06/24/2019 389% Piper Sandler → $10 Initiates Coverage On → Overweight
10/19/2018 437.9% IFS Securities → $11 Downgrades Strong Buy → Outperform

What is the target price for Rockwell Medical (RMTI)?

The latest price target for Rockwell Medical (NASDAQ: RMTI) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $5.00 expecting RMTI to rise to within 12 months (a possible 144.50% upside). 10 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Rockwell Medical (RMTI)?

The latest analyst rating for Rockwell Medical (NASDAQ: RMTI) was provided by Maxim Group, and Rockwell Medical initiated their buy rating.

When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rockwell Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rockwell Medical was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.

Is the Analyst Rating Rockwell Medical (RMTI) correct?

While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a initiated with a price target of $0.00 to $5.00. The current price Rockwell Medical (RMTI) is trading at is $2.05, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment